secwatch.observer — SEC 8-K summary
======================================

Issuer:     Moleculin Biotech, Inc. (MBRX)
CIK:        0001659617
Form:       8-K
Filed at:   2026-02-18T23:59:59+00:00
Accession:  0001437749-26-004558
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Moleculin posts new investor presentation on website
----------------------------------------------------

- Filed under Item 7.01 as Regulation FD disclosure with Exhibit 99.1.
- Presentation is dated February 2026; actual content is an image exhibit not parsed.
- No specific financial, clinical, or operational data disclosed in the 8-K text.
- Investors should review the presentation on the company's website for details.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1659617/000143774926004558/0001437749-26-004558-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1659617/000143774926004558/mbrx20260217_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-26-004558

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer